| 2568- | RES, | Resveratrol: A Miracle Drug for Vascular Pathologies |
| - | Review, | Var, | NA |
| 2567- | RES, | Neuroprotective Effects of Resveratrol in Ischemic Brain Injury |
| - | Review, | Stroke, | NA |
| 2566- | RES, | A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke |
| - | Review, | Stroke, | NA |
| 2564- | RES, | Effect of resveratrol on platelet aggregation by fibrinogen protection |
| - | in-vitro, | NA, | NA |
| 2467- | RES, | Resveratrol inhibits Ca2+ signals and aggregation of platelets |
| - | in-vitro, | Nor, | NA |
| 2440- | RES, | Resveratrol inhibits Hexokinases II mediated glycolysis in non-small cell lung cancer via targeting Akt signaling pathway |
| - | in-vitro, | Lung, | H460 | - | in-vivo, | Lung, | NA | - | in-vitro, | Lung, | H1650 | - | in-vitro, | Lung, | HCC827 |
| 2439- | RES, | By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice |
| - | in-vitro, | HCC, | HCCLM3 | - | in-vitro, | Nor, | L02 | - | in-vitro, | HCC, | SMMC-7721 cell | - | in-vitro, | HCC, | Bel-7402 | - | in-vitro, | HCC, | HUH7 |
| 2471- | RES, | Resveratrol Regulates Glucose and Lipid Metabolism in Diabetic Rats by Inhibition of PDK1/AKT Phosphorylation and HIF-1α Expression |
| - | in-vivo, | Diabetic, | NA |
| 2472- | RES, | Resveratrol Restores Sirtuin 1 (SIRT1) Activity and Pyruvate Dehydrogenase Kinase 1 (PDK1) Expression after Hemorrhagic Injury in a Rat Model |
| - | in-vivo, | Nor, | NA |
| 1492- | RES, | Resveratrol: Biological and pharmaceutical properties as anticancer molecule |
| - | Review, | Var, | NA |
| 1491- | RES, | Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy |
| 1490- | RES, | Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues |
| - | Review, | Var, | NA |
| 1506- | RES, | Epigenetic targets of bioactive dietary components for cancer prevention and therapy |
| - | Review, | NA, | NA |
| 1489- | RES, | Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer |
| - | Review, | Var, | NA |
| 1511- | RES, | Chemo, | Combination therapy in combating cancer |
| - | Review, | NA, | NA |
| 1282- | RES, | Resveratrol Inhibits CD4+ T Cell Activation by Enhancing the Expression and Activity of Sirt1 |
| - | vitro+vivo, | NA, | NA |
| 1391- | RES, | BBR, | Effects of Resveratrol, Berberine and Their Combinations on Reactive Oxygen Species, Survival and Apoptosis in Human Squamous Carcinoma (SCC-25) Cells |
| - | in-vitro, | Tong, | SCC25 |
| 4153- | RES, | Effect of oral resveratrol on the BDNF gene expression in the hippocampus of the rat brain |
| - | in-vivo, | AD, | NA |
| 4154- | RES, | Resveratrol improves postnatal hippocampal neurogenesis and brain derived neurotrophic factor in prenatally stressed rats |
| - | in-vivo, | AD, | NA |
| 3612- | RES, | Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential |
| - | Review, | AD, | NA |
| 3613- | RES, | Resveratrol for Alzheimer's disease |
| - | Review, | AD, | NA |
| 3614- | RES, | Resveratrol--a boon for treating Alzheimer's disease? |
| - | Review, | AD, | NA |
| 3858- | RES, | Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer’s Disease Treatment |
| - | Review, | AD, | NA |
| 3863- | RES, | MEL, | VitA,RetA, | Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's Disease |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 3798- | RES, | Resveratrol reverses hippocampal synaptic markers injury and SIRT1 inhibition against developmental Pb exposure |
| - | in-vivo, | NA, | NA |
| 6417- | RES, | CUR, | Curcumin and Resveratrol Synergy: A Multi-Target Strategy Against Neurodegenerative Disease Pathology |
| - | Review, | AD, | NA |
| 6420- | RES, | Resveratrol Regulates Mitochondrial Biogenesis and Fission/Fusion to Attenuate Rotenone-Induced Neurotoxicity |
| - | in-vivo, | Park, | NA |
| 6423- | RES, | Resveratrol Regulates Mitochondrial Biogenesis and Fission/Fusion to Attenuate Rotenone-Induced Neurotoxicity |
| - | vitro+vivo, | Park, | NA |
| 7150- | RES, | Modulation of the PI3K/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity |
| - | Review, | Var, | NA |
| 7147- | RES, | EGCG, | GEN, | Echi, | FIS | Antithrombotic effects of naturally derived products on coagulation and platelet function |
| - | Review, | Nor, | NA |
| 101- | RES, | Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis |
| - | in-vitro, | GC, | SGC-7901 |
| 105- | RES, | QC, | The Effect of Resveratrol and Quercetin on Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem Cell |
| - | in-vitro, | Pca, | PANC1 |
| 104- | RES, | QC, | Resveratrol and Quercetin in Combination Have Anticancer Activity in Colon Cancer Cells and Repress Oncogenic microRNA-27a |
| - | in-vitro, | Colon, | HT-29 |
| 103- | RES, | CUR, | QC, | The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice |
| - | vitro+vivo, | BC, | 4T1 |
| 102- | RES, | Effect of resveratrol on proliferation and apoptosis of human pancreatic cancer MIA PaCa-2 cells may involve inhibition of the Hedgehog signaling pathway |
| - | in-vitro, | PC, | MIA PaCa-2 |
| 1047- | RES, | Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells |
| - | in-vitro, | Lung, | H1299 | - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H460 |
| 967- | RES, | Resveratrol binds and inhibits transcription factor HIF-1α in pancreatic cancer |
| - | Analysis, | PC, | NA |
| 882- | RES, | Resveratrol: A Double-Edged Sword in Health Benefits |
| - | Review, | NA, | NA |
| 880- | RES, | Forkhead Proteins Are Critical for Bone Morphogenetic Protein-2 Regulation and Anti-tumor Activity of Resveratrol |
| - | in-vitro, | BC, | MDA-MB-231 |
| 881- | RES, | Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | PC, | PANC1 | - | in-vitro, | Pca, | DU145 |
| 879- | RES, | Evidence that TNF-β induces proliferation in colorectal cancer cells and resveratrol can down-modulate it |
| - | in-vitro, | CRC, | HCT116 |
| 924- | RES, | Resveratrol sequentially induces replication and oxidative stresses to drive p53-CXCR2 mediated cellular senescence in cancer cells |
| - | in-vitro, | OS, | U2OS | - | in-vitro, | Lung, | A549 |
| 878- | RES, | Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression |
| - | vitro+vivo, | CRC, | LoVo |
| 877- | RES, | Resveratrol Inhibits Invasion and Metastasis of Colorectal Cancer Cells via MALAT1 Mediated Wnt/β-Catenin Signal Pathway |
| - | in-vitro, | CRC, | LoVo | - | in-vitro, | CRC, | HCT116 |
| 885- | RES, | Resveratrol induces intracellular Ca2 + rise via T-type Ca2 + channels in a mesothelioma cell line |
| - | in-vitro, | RCC, | REN | - | in-vitro, | Nor, | MeT5A |
| 871- | RES, | CUR, | QC, | The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice |
| - | in-vitro, | BC, | 4T1 | - | in-vivo, | BC, | 4T1 |
| 884- | RES, | PTS, | Resveratrol and Pterostilbene Exhibit Anticancer Properties Involving the Downregulation of HPV Oncoprotein E6 in Cervical Cancer Cells |
| - | in-vitro, | Cerv, | HeLa |
| 883- | RES, | Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy |
| 993- | RES, | Resveratrol reverses the Warburg effect by targeting the pyruvate dehydrogenase complex in colon cancer cells |
| - | in-vitro, | CRC, | Caco-2 | - | in-vivo, | Nor, | HCEC 1CT |
| 4706- | RES, | Resveratrol as a circadian clock modulator: mechanisms of action and therapeutic applications |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid